Previous Page  12 / 24 Next Page
Information
Show Menu
Previous Page 12 / 24 Next Page
Page Background

12 JCN supplement

2018,Vol 32, No 4

WOUND DEBRIDEMENT

weeks of conservative treatment with

autolytic debridement at the general

practice there was no improvement

in the condition of the wound and

so, after discussion with the GP, Mr A

was referred to the local plastics unit

for surgical debridement and to the

community tissue viability service.

Mr A continued to receive a further

six weeks of conventional treatment

of twice weekly dressing changes

with hydrogel to encourage autolytic

debridement, but again with little

progress. He was also prescribed oral

antibiotics by his GP, as the GPN

identified signs of wound infection.

At presentation to the tissue

viability clinic after 10 weeks’

treatment, Mr A’s wound was covered

with necrotic, leathery eschar (

Figure

3

). As no staff were trained to remove

the eschar with sharp debridement,

UCS premoistened debridement

cloths were used to mechanically

debride the wound twice weekly.

After just one week, the eschar had

lifted leaving islands of granulation

tissue in a sloughy wound bed

(

Figures 4

and

5

).

Mr A’s vascular assessment showed

no signs of arterial insufficiency so

compression therapy was started. As

he was active and wanted to continue

to enjoy playing in his bowls team,

he was anxious and concerned about

compression bandages restricting his

activity. He had little oedema in his

lower limb and so was fitted with a

juxtalite

®

compression wrap device

(medi UK). This also allowed him to

manage his personal hygiene needs

and skin care during treatment. After

two further weeks and four clinic

visits, the condition of the wound

bed had greatly improved — wound

edges had advanced and a reduction

in wound size could be seen. After

three weeks of treatment at the tissue

viability clinic, he was discharged back

to the GPN with a self-care regimen,

involving skin care and compression

therapy with juxtalite, as surgical

referral was no longer required.

BIOFILM MANAGEMENT

A biofilm is a complex microbial

community, consisting of bacteria

embedded in a protective matrix

of sugars and proteins commonly

Figure 3.

Figures 4 and 5.

4

5

with the result, as he said that the

ulcers were becoming uncomfortable

under bandages and beginning to

itch, but that he found the process of

debridement soothing.

Case report two

Mr A was an 80-year-old, retired

gentleman, who had a healthy and

active lifestyle. He had no particular

past medical history or comorbidities.

He presented to the tissue viability

clinic for leg ulcer assessment

following referral from a general

practice nurse (GPN) for leg

ulcer management.

During a game of bowls 11 weeks

earlier, he had tripped and obtained a

traumatic pre-tibial laceration to his

left leg. He saw his GPN on the day

of injury and started twice weekly

dressing changes. However, after four

Figure 1.

Figure 2.

found in chronic wounds (Keast

et al, 2014). Recent literature has

demonstrated increasing awareness

of their presence in the majority of

non-healing wounds (Malone et al,

2017), and the role that biofilms play

in delayed wound healing (Metcalf et

al, 2014; Schultz, 2015).

Biofilms provide a protective

environment for microorganisms

embedded within them, improving

their tolerance to the host’s immune

system, topical antimicrobial agents

and environmental stresses, which

is why they can stall wound healing.

It is important to physically remove